Regional haemodynamic effects of urocortin in the anaesthetized rat

Eur J Pharmacol. 2003 Apr 18;466(3):317-21. doi: 10.1016/s0014-2999(03)01568-1.

Abstract

Urocortin is an endogenous vasodilator peptide that is related to corticotrophin-releasing factor. We examined the haemodynamic effects of urocortin in thiobutabarbital-anaesthetized rats, via the triple-isotope microspheres technique. Urocortin (3 nmol/kg, i.v. bolus) reduced mean arterial pressure (-25 mm Hg) through a decrease in total peripheral resistance (-43%). This was associated with an increase in cardiac output (+24%) and vasodilatation of the following tissues: heart and stomach (approximately 300% of baseline); liver, intestine, caecum/colon, skeletal muscle and skin (approximately 200%); and testes (approximately 150%). Arterial conductances of the kidneys, spleen and brain were unaffected by urocortin. Neither the vehicle (0.9% NaCl) nor a low dose of urocortin (0.3 nmol/kg) altered any measurements. Therefore, urocortin causes generalized vasodilatation as follows: heart and stomach>liver, intestine, caecum/colon, skeletal muscle and skin>testes.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthesia
  • Animals
  • Blood Pressure / drug effects
  • Brain / blood supply
  • Cardiac Output / drug effects
  • Cecum / blood supply
  • Colon / blood supply
  • Corticotropin-Releasing Hormone / pharmacology*
  • Dose-Response Relationship, Drug
  • Heart Rate / drug effects
  • Hemodynamics / drug effects*
  • Injections, Intravenous
  • Kidney / blood supply
  • Liver / blood supply
  • Male
  • Muscle, Skeletal / blood supply
  • Neuroprotective Agents / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Regional Blood Flow / drug effects
  • Skin / blood supply
  • Spleen / blood supply
  • Stomach / blood supply
  • Urocortins
  • Vascular Resistance / drug effects

Substances

  • Neuroprotective Agents
  • Urocortins
  • Corticotropin-Releasing Hormone